Activation of heterologously expressed D3 dopamine receptors: comparison with D2 dopamine receptors
about
Antagonism of the effects of (+)-PD 128907 on midbrain dopamine neurones in rat brain slices by a selective D2 receptor antagonist L-741,626.Dopamine Receptors and NeurodegenerationThe transfection of BDNF to dopamine neurons potentiates the effect of dopamine D3 receptor agonist recovering the striatal innervation, dendritic spines and motor behavior in an aged rat model of Parkinson's diseaseA paradoxical regulation of the dopamine D3 receptor expression suggests the involvement of an anterograde factor from dopamine neuronsG protein-coupled receptor kinase 4 (GRK4) regulates the phosphorylation and function of the dopamine D3 receptor.Concentration of receptor and ligand revisited in a modified receptor binding protocol for high-affinity radioligands: [3H]Spiperone binding to D2 and D3 dopamine receptorsEvaluation of D2 and D3 dopamine receptor selective compounds on L-dopa-dependent abnormal involuntary movements in rats.Dopamine transporter blockade increases LTP in the CA1 region of the rat hippocampus via activation of the D3 dopamine receptorEx Vivo Characterization of a Novel Iodine-123-Labelled Aminomethylchroman as a Potential Agonist Ligand for SPECT Imaging of Dopamine D2/3 Receptors.Yawning and hypothermia in rats: effects of dopamine D3 and D2 agonists and antagonists.Comparison between the pharmacology of dopamine receptors mediating the inhibition of cell firing in rat brain slices through the substantia nigra pars compacta and ventral tegmental area.Localization of dopamine D3 receptors to mesolimbic and D2 receptors to mesostriatal regions of human forebrain.Molecular characterization of individual D3 dopamine receptor-expressing cells isolated from multiple brain regions of a novel mouse modelD2-like dopamine and β-adrenergic receptors form a signaling complex that integrates Gs- and Gi-mediated regulation of adenylyl cyclase.A review of the discovery, pharmacological characterization, and behavioral effects of the dopamine D2-like receptor antagonist eticlopride.Evaluation of the D3 dopamine receptor selective agonist/partial agonist PG01042 on L-dopa dependent animal involuntary movements in rats.Pharmacological characterization of 2-methoxy-N-propylnorapomorphine's interactions with D2 and D3 dopamine receptors.Advances and challenges in the search for D2 and D3 dopamine receptor-selective compounds.Synthesis and evaluation in rats of homologous series of [(18)F]-labeled dopamine D 2/3 receptor agonists based on the 2-aminomethylchroman scaffold as potential PET tracersEfficient functional coupling of the human D3 dopamine receptor to G(o) subtype of G proteins in SH-SY5Y cells.Abnormalities of Dopamine D3 Receptor Signaling in the Diseased Brain.Pharmacological characterization of extracellular acidification rate responses in human D2(long), D3 and D4.4 receptors expressed in Chinese hamster ovary cellsCharacterization of [(3) H]LS-3-134, a novel arylamide phenylpiperazine D3 dopamine receptor selective radioligand.Pharmacological analysis of dopamine stimulation of [35S]-GTP gamma S binding via human D2short and D2long dopamine receptors expressed in recombinant cells.In vitro pharmacological profile of YM-43611, a novel D2-like receptor antagonist with high affinity and selectivity for dopamine D3 and D4 receptors.
P2860
Q24674289-C4FCD227-46D3-4D9F-AD1C-7F2B058C1E17Q26783348-450CE8BC-3734-4E51-8F34-DCF846205720Q27316252-1530FEAD-B6E0-4515-AE0E-69875EFAF64EQ28368794-534E814E-EFD4-4B5A-9511-7ABA872D943DQ30435176-F6D267F2-64E2-41B8-AA1A-FA525FF6CDEAQ33759179-EF6A103B-AB93-49DA-887C-CA0D62BBE5AFQ33931801-039ECCD5-288D-4DFD-AA22-EB5D8562E93FQ34468678-8B525B1F-BDD1-4AD4-9B38-6EF131535788Q34918396-E5F5A151-FEFA-42D0-BEB4-EEB115A6CD1CQ34982537-DB2646DD-CCEE-4828-98F0-1F0F2E3AC1B1Q35874594-3FD6BCB5-AF46-4FE1-9707-3B634C14DC17Q35904983-EFE7DDA2-D425-45F7-8F8F-05DD2F333F8FQ36137258-272A529C-D733-4FED-9F14-C3D0C3903A1BQ36205276-926BE847-FBC8-4B85-8238-53739DDB907DQ37272767-34D44215-2770-49E6-B258-F0B4852AAFB2Q37286549-90DFB4CF-0FD2-4B85-BD30-1B2FEB55473CQ37351558-98C56F97-B40F-4978-880B-04050967A298Q38656262-DAEA1F99-C288-4AEC-8FDF-D36ABBD1052BQ40702593-6880B23E-4E79-401E-A875-740300441F86Q40915306-CC7A5B18-FC34-4D80-BFDB-266110D97263Q41456216-2E8BAD9A-E3C5-43E3-8F62-E41884B4517AQ41978274-63062A36-5F09-4271-AC6A-4BA7463B2C0DQ41993974-F9D872F2-C422-4CEE-803A-E3EE31CE3F34Q42704214-D04C2F0F-91D9-4DCE-BD25-BBF3CFCCF94AQ42704675-F5E88401-D0EE-4BF4-BF04-B119EF81110B
P2860
Activation of heterologously expressed D3 dopamine receptors: comparison with D2 dopamine receptors
description
1994 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի հունվարին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1994
@ast
scientific journal article
@en
vedecký článok (publikovaný 1994/01/01)
@sk
vědecký článek publikovaný v roce 1994
@cs
wetenschappelijk artikel (gepubliceerd op 1994/01/01)
@nl
наукова стаття, опублікована в січні 1994
@uk
مقالة علمية (نشرت عام 1994)
@ar
name
Activation of heterologously e ...... son with D2 dopamine receptors
@ast
Activation of heterologously e ...... son with D2 dopamine receptors
@en
Activation of heterologously e ...... son with D2 dopamine receptors
@nl
type
label
Activation of heterologously e ...... son with D2 dopamine receptors
@ast
Activation of heterologously e ...... son with D2 dopamine receptors
@en
Activation of heterologously e ...... son with D2 dopamine receptors
@nl
prefLabel
Activation of heterologously e ...... son with D2 dopamine receptors
@ast
Activation of heterologously e ...... son with D2 dopamine receptors
@en
Activation of heterologously e ...... son with D2 dopamine receptors
@nl
P2093
P1476
Activation of heterologously e ...... son with D2 dopamine receptors
@en
P2093
C. L. Chio
M. E. Lajiness
R. M. Huff
P577
1994-01-01T00:00:00Z